Antithrombin Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2027

The global antithrombin treatment market size surpassed US$ 0.55 Bn in 2019 and to reach 0.79 billion by 2027 with a CAGR of 5.4% from 2021 to 2027.

Overview

• Antithrombotic drugs help in the prevention or inhibition of thrombus by mimicking the role of antithrombin, a protein molecule produced in the body, which helps in clotting. Antithrombin is a small protein involved in the inactivation of several enzymes in the coagulation system. It is used in several medical treatments such as hereditary antithrombin deficiency, ECMO, DIC, and sepsis. Engineered recombinant antithrombin has gained clinical significance in recent years for the prevention of various peripartum and perioperative thromboembolic events or blood clots.
• The antithrombin treatment market is currently a booming one, due to rise in awareness and acceptance of antithrombin therapy in proven applications and adoption of medical conditions such as hereditary antithrombin deficiency, and prevention of various peripartum and perioperative thromboembolic events or blood clots, ECMO, DIC, and sepsis. Moreover, increasing use in combination therapy of antithrombin with heparin is likely to further support the growth of the market.
• North America dominate the global antithrombin treatment market in 2018 and the trend is anticipated to continue during the forecast period. Early adoption of advaced therapies and well established healthcare infrastructure accentuate antithrombin treatment market growth in the region.
• Asia Pacific is likely to be a highly lucrative market for the antithrombin treatment market and it is expected to expand at a high CAGR during the forecast period. Rise in demand of therapeutic antithrombin, low pricing pressure, increasing healthcare expenditure are key factors likely to boost antithrombin treatment market in Asia Pacific.

Exploring Use of Antithrombin Products to Drive Global Antithrombin Treatment Market

• Antithrombotic drugs act by imitating antithrombin protein, molecule which is produced by liver and is involved in clotting and thus support in the prevention or inhibition of thrombus. Antithrombin protein molecule is synthesized by the liver, and along with other benefits, it has coagulant effects.
• Engineered recombinant antithrombin has gained clinical significant in recent years for the prevention of various peri-partum and peri-operative thromboembolic events or blood clots.
• Discovering new indications over the existing ones will create gigantic opportunity with rising demand during the forecast period. For instance. In Feb 2014, rEVO Biologics Inc. submitted IND application for ATryn for the treatment of preeclampsia with the USFDA
• Exploring new applications of antithrombin products drive the growth of global antithrombin market. .

Therapeutic Segment to Dominate Antithrombin Treatment Market

• In terms of application, the global antithrombin treatment market has been segmented into therapeutic, research and diagnostics. Therapeutic segment is dominate the market and is continue its dominance during the forecast period. Increasing use of antithrombin therapy as an anticoagulant for the prevention of clots before, during, or after surgery or birthing in patients with hereditary antithrombin deficiency is projected to support the growth of the segment during the forecast period

Human Segment Hold a Major Share of Global Antithrombin Treatment Market

• In terms of source, the global antithrombin treatment market has been classified into human, goat milk and others.
• The human segment dominated the antithrombin treatment market. Rising investments in protein therapeutics used in rare disease by large pharma companies are likely to boost the segment during the forecast period

Lyophilized Segment to Dominate Global Antithrombin Treatment Market

• Based on dosage form, the global antithrombin treatment market has been segmented into lyophilized and liquid. Availability of lyophilized antithrombin therapeutic products is a major factor that drives the segment. Stability of this dosage form in therapeutic preparations is contribute to increase use of lyophilized dosage form and thereby drive the growth of segment

North America to Dominate Global Antithrombin Treatment Market

• In terms of region, the global antithrombin treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global antithrombin treatment market in 2018, followed by Europe.
• North America accounted for major share of the global antithrombin treatment market in 2018. Supportive healthcare and payer infrastructure, and hub for key industry players are the major drivers of the antithrombin treatment market in the region.
• The antithrombin treatment market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. The rapidly rising population with prevalence hereditary antithrombin deficiency in countries such as India and China provide large market for antithrombin therapy.

Competitive Landscape

• The global antithrombin treatment market is fragmented in terms of number of players. Key players in the global antithrombin treatment market include rEVO Biologics, Inc., Grifols, Shire plc., CSL Limited, Kedrion S.p.A, Octapharma AG, Dem ilac Inc., Lee Bisolutions, Diapharma and Scripps Laboratories, Inc

The global antithrombin treatment market has been segmented as follows:

By Application

• • Therapeutic
  • Research
  • Diagnostics

By Source

• • Human
  • Goat Milk
  • Others

By Dosage Form

• • Lyophilized
  • Liquid

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific          
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Scope of Report

VRR’s report on the global antithrombin treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2027. The report provides revenue of the global antithrombin treatment market for the period 2016–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global antithrombin treatment market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global antithrombin treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global antithrombin treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global antithrombin treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global antithrombin treatment market.

The report delves into the competitive landscape of the global antithrombin treatment market. Key players operating in the global antithrombin treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global antithrombin treatment market that have been profiled in this report.

Key Questions Answered in Global Antithrombin Treatment Market Report

• What is the scope of growth for product companies in the global antithrombin treatment market?
• What will be the Y-o-Y growth of the global antithrombin treatment market between 2019 and 2027?
• What is the influence of changing trends in technologies on the global antithrombin treatment market?
• Will North America continue to be the most profitable market for antithrombin treatment providers?
• Which factors are anticipated to hamper the growth of the global antithrombin treatment market during the forecast period?
• Which are the leading companies in the global antithrombin treatment market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global antithrombin treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global antithrombin treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the antithrombin treatment market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the antithrombin treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global antithrombin treatment market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global antithrombin treatment more reliably and accurately.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

        4.1.1. Application Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global  Antithrombin Treatment Market Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis Globally: Snapshot

    5.3. Healthcare Industry Overview

6. Global Antithrombin Treatment Market Analysis and Forecasts, By Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        6.3.1. Therapeutic

        6.3.2. Research

        6.3.3. Diagnostics

    6.4. Global Antithrombin Treatment Market Attractiveness By Application

7. Global Antithrombin Treatment Market Analysis and Forecasts, By Source

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        7.3.1. Human

        7.3.2. Goat Milk

        7.3.3. Others (Bovine, etc.)

    7.4. Global Antithrombin Treatment Market Attractiveness By Source

8. Global  Antithrombin Treatment Analysis and Forecasts, By Dosage Form

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        8.3.1. Lyophilized

        8.3.2. Liquid

    8.4. Global Antithrombin Treatment Market Attractiveness By Dosage Form

9. Global Antithrombin Treatment Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Global Antithrombin Treatment Market Value  Forecast By Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Antithrombin Treatment Market Attractiveness By Country/Region

10. North America Antithrombin Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America  Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        10.2.1. Therapeutic

        10.2.2. Research

        10.2.3. Diagnostics

    10.3. North America  Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        10.3.1. Human

        10.3.2. Goat Milk

        10.3.3. Others (Bovine, etc.)

    10.4. North America  Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        10.4.1. Lyophilized

        10.4.2. Liquid

    10.5. North America  Antithrombin Treatment Market Value  Forecast By Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America  Antithrombin Treatment Market Attractiveness Analysis

        10.6.1. By Application

        10.6.2. By Source

        10.6.3. By Dosage Form

        10.6.4. By Country

11. Europe Antithrombin Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        11.2.1. Therapeutic

        11.2.2. Research

        11.2.3. Diagnostics

    11.3. Europe Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        11.3.1. Human

        11.3.2. Goat Milk

        11.3.3. Others (Bovine, etc.)

    11.4. Europe Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        11.4.1. Lyophilized

        11.4.2. Liquid

    11.5. Europe Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Antithrombin Treatment Market Attractiveness Analysis

        11.6.1. By Application

        11.6.2. By Source

        11.6.3. By Dosage Form

        11.6.4. By Country/Sub-region

12. Asia Pacific Antithrombin Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        12.2.1. Therapeutic

        12.2.2. Research

        12.2.3. Diagnostics

    12.3. Asia Pacific Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        12.3.1. Human

        12.3.2. Goat Milk

        12.3.3. Others (Bovine, etc.)

    12.4. Asia Pacific Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        12.4.1. Lyophilized

        12.4.2. Liquid

    12.5. Asia Pacific Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Antithrombin Treatment Market Attractiveness Analysis

        12.6.1. By Application

        12.6.2. By Source

        12.6.3. By Dosage Form

        12.6.4. By Country/Sub-region

13. Latin America Antithrombin Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        13.2.1. Therapeutic

        13.2.2. Research

        13.2.3. Diagnostics

    13.3. Latin America Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        13.3.1. Human

        13.3.2. Goat Milk

        13.3.3. Others (Bovine, etc.)

    13.4. Latin America Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        13.4.1. Lyophilized

        13.4.2. Liquid

    13.5. Latin America Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Antithrombin Treatment Market Attractiveness Analysis

        13.6.1. By Application

        13.6.2. By Source

        13.6.3. By Dosage Form

        13.6.4. By Country/Sub-region

14. Middle East & Africa Antithrombin Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        14.2.1. Therapeutic

        14.2.2. Research

        14.2.3. Diagnostics

    14.3. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        14.3.1. Human

        14.3.2. Goat Milk

        14.3.3. Others (Bovine, etc.)

    14.4. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        14.4.1. Lyophilized

        14.4.2. Liquid

    14.5. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Antithrombin Treatment Market Attractiveness Analysis

        14.6.1. By Application

        14.6.2. By Source

        14.6.3. By Dosage Form

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking By Company (2018)

    15.3. Company Profiles

        15.3.1. rEVO Biologics, Inc.

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis.

        15.3.2. Grifols

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis.

        15.3.3. Shire plc.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis.

        15.3.4. CSL Limited

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis.

        15.3.5. Kedrion S.p.A

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis.

        15.3.6. Octapharma AG

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis.

        15.3.7. Dem ilac Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis.

        15.3.8. Lee Bisolutions

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis.

        15.3.9. Diapharma

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis.

        15.3.10. Scripps Laboratories, Inc.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis.